Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Cerenkov Probes to detect Redox Status

Alejandro Arroyo, Alexander Kachur, Elizabeth Browning, Eric Blankemeyer, Anatoliy Popov and Edward Delikatny
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1065;
Alejandro Arroyo
1Department of Radiology University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Kachur
1Department of Radiology University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Browning
1Department of Radiology University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Blankemeyer
1Department of Radiology University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anatoliy Popov
1Department of Radiology University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Delikatny
1Department of Radiology University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1065

Objectives The objective is to develop a robust method to utilize the emission of Cerenkov photons in conjunction with functional fluorinated chromophores to determine redox state in tissue. Resazurin (RA) is a commonly used viability dye and redox sensor. When reduced in cells, RA is converted into resorufin (RAred), a highly fluorescent molecule. Here we describe fluorination, characterization and application of the resulting molecule in vitro, in cells and in mouse models.

Methods RA was fluorinated using electrophilic fluorination under acidic conditions. The resulting mixture of fluorinated derivatives was purified using preparative HPLC; 5 fractions were identified and collected. Mass spectrometry, UV-vis spectroscopy, NMR (1H and 19F) and pKa studies were run to fully characterize the compounds. To determine the reduction capability of MFRA and DFRA, chemical reduction of the molecule was performed using sodium dithionite. DU145 cell studies determined the feasibility of the compounds to be reduced in cellulo. Preliminary tumor bearing mouse studies were run to determine the delivery of the probe to the tumor area, tracking the probe with both aPET and optical imaging.

Results Mass spectrometry analysis confirmed the synthesis of mono and difluorinated compounds. 1H-NMR and 19F-NMR analysis confirmed the presence of two isomers of monoflurinated resazurin (MFRA) in one of the fractions and an isomer of difluororesazurin (DFRA) in each of two fractions. The pKa results followed a trend of higher acidity with increased degree of fluorination. Analysis of the Cerenkov emission using an IVIS Spectrum determined that both MFRA (with the addition of FDG as photon source) and 18F-MFRA were able to be reduced chemically. The reduced compound is highly fluorescent resulting in a longer wavelength emission due to Cerenkov Radiation Energy Transfer (CRET). The maximum ratio of emission between MFRA and MFRAred was 3.5 at 620 nm. The difference in photonic emissions between 620-660 nm suggests that these are the best filters to use for in cellulo and/or in vivo application. A similar study with DFRA showed comparable results between the 19F and the 18F-labeled compounds. Cell studies demonstrated that DU145 prostate cancer cells are able to reduce both MFRA and DFRA readily. Preliminary mouse studies show a maximum accumulation of 0.25% injected dose in the tumor. Excretion is primarily renal and to a lesser extent hepatic within a couple of hours.

Conclusions Successful fluorination of the resazurin molecule was achieved. Chemical and cellular reduction led to increased fluorescence capability of MFRAred and DFRAred leading to a bathochromic shift of Cerenkov emission due to CRET. Cellular activity of the fluorinated derivatives is an indication of a possible in vivo application. The detection of redox stress is a potential tool to non-invasively detect several medically relevant scenarios including antioxidant studies, inflammation and potentially neurodegenerative diseases. The eventual impact of this technique lies in the ability translate it into the clinic coupled with PET for a dual imaging modality.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cerenkov Probes to detect Redox Status
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Cerenkov Probes to detect Redox Status
Alejandro Arroyo, Alexander Kachur, Elizabeth Browning, Eric Blankemeyer, Anatoliy Popov, Edward Delikatny
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1065;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cerenkov Probes to detect Redox Status
Alejandro Arroyo, Alexander Kachur, Elizabeth Browning, Eric Blankemeyer, Anatoliy Popov, Edward Delikatny
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1065;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Novel Radiochemistry & Chelation Posters

  • New Precursor in Improved 18F-Nifene Synthesis for Imaging Nicotinic Receptors
  • Optimized peptide heterodimer for uPAR-αvβ3 dual-targeted cancer imaging
  • Radiosynthesis of Re(CO)3(18F-FEDA), a structural analog of 99mTc(CO)3(FEDA) and new PET tracer for renal imaging and renal function assessment
Show more SPECIAL MTA: Novel Radiochemistry & Chelation Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire